Litigation Details for AstraZeneca AB v. Wockhardt Bio AG (D. Del. 2014)
✉ Email this page to a colleague
AstraZeneca AB v. Wockhardt Bio AG (D. Del. 2014)
Docket | ⤷ Sign Up | Date Filed | 2014-05-23 |
Court | District Court, D. Delaware | Date Terminated | 2017-02-02 |
Cause | 35:271 Patent Infringement | Assigned To | Gregory Moneta Sleet |
Jury Demand | None | Referred To | |
Parties | WOCKHARDT USA LLC | ||
Patents | 6,395,767; 7,951,400; RE44,186 | ||
Attorneys | Oderah C. Nwaeze | ||
Firms | Eckert Seamans Cherin & Mellott, LLC | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in AstraZeneca AB v. Wockhardt Bio AG
Details for AstraZeneca AB v. Wockhardt Bio AG (D. Del. 2014)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2014-05-23 | 1 | 05/23/14 Page 4 of 8 PageID #: 4 6,395,767 (“the ’767 patent”), which issued on May 28, 2002. A true…expiration of U.S. Patent Nos. RE44,186 (“the RE’186 patent”) and 7,951,400 (“the ’400 patent”) (together, … This is an action for patent infringement arising under the patent laws of the United States, … PATENTS-IN-SUIT 14. On April 30, 2013, the U.S. Patent and Trademark Office…Peptidase IV and Method.” The RE’186 patent is a reissue of U.S. Patent No. | External link to document | |
2014-09-23 | 16 | than April 15, 2014. Date of Expiration of Patent: 7,951,400 (November 30, 2028); RE 44,186 (July 31, 2023… Amended Supplemental information for patent cases involving an Abbreviated New Drug Application…2014 2 February 2017 1:14-cv-00667 830 Patent None District Court, D. Delaware | External link to document | |
2014-05-23 | 4 | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE44,186; 7,951,400;. (dmp, ) (Entered… 23 May 2014 1:14-cv-00667 830 Patent None District Court, D. Delaware | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |